Radicava FDA Approval History
FDA Approved: Yes (First approved May 5, 2017)
Brand name: Radicava
Generic name: edaravone
Dosage form: Injection
Company: Mitsubishi Tanabe Pharma
Treatment for: Amyotrophic Lateral Sclerosis
Radicava (edaravone) is a free radical scavenger that relieves the effects of oxidative stress, a likely factor in the onset and progression of amyotrophic lateral sclerosis.
Development Timeline for Radicava
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.